Related references
Note: Only part of the references are listed.Antithrombin III for critically ill patients: a systematic review with meta-analysis and trial sequential analysis
Mikkel Allingstrup et al.
INTENSIVE CARE MEDICINE (2016)
Efficacy and safety of anticoagulant therapy in three specific populations with sepsis: a meta-analysis of randomized controlled trials
Y. Umemura et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2016)
Antithrombin: anti-inflammatory properties and clinical applications
Jerrold H. Levy et al.
THROMBOSIS AND HAEMOSTASIS (2016)
Influence of Reported Study Design Characteristics on Intervention Effect Estimates From Randomized, Controlled Trials
Jelena Savovic et al.
ANNALS OF INTERNAL MEDICINE (2012)
A systematic review of antithrombin concentrate use in patients with disseminated intravascular coagulation of severe sepsis
Christian J. Wiedermann et al.
BLOOD COAGULATION & FIBRINOLYSIS (2006)
Treatment effects of high-dose antithrombin without concomitant heparin in patients with severe sepsis with or without disseminated intravascular coagulation
J Kienast et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2006)
High-dose a randomized antithrombin III in severe sepsis -: A randomized controlled trial
BL Warren et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2001)
Share Paper
